温氏食品集团股份有限公司 独立董事江强2024年度述职报告 作为温氏食品集团股份有限公司（以下简称"公司"）的独立董事，本人根据 《上市公司治理准则》《上市公司独立董事管理办法》等有关法律、法规以及《公 司章程》《独立董事工作制度》等公司制度的规定，在2024年度工作中，本人定 期了解公司经营情况，认真履行独立董事的职责，恪尽职守，勤勉尽责。积极出 席相关会议，认真审阅会议议案及相关材料，积极参与各议题的讨论，对公司重 点关注事项发表了意见，切实维护了公司和股东特别是中小股东的合法权益。根 据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 有关要求，现就本人在2024年度履行独立董事职责的情况报告如下： 一、基本情况 本人江强，汉族，1963年出生，中国国籍，未有任何国家和地区的永久海外 居留权，研究生学历。曾任广东省电子信息产业集团有限公司董事长，广东风华 高新科技股份有限公司董事、总经理，春和集团有限公司董事、总裁等。现任杭 州烈焰网络技术有限公司顾问、公司独立董事。 报告期内，本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求，不存在影响独立性的情况。 二、年度履职 ...

温氏食品集团股份有限公司 独立董事陆正华2024年度述职报告 作为温氏食品集团股份有限公司（以下简称"公司"）的独立董事，本人根据 《上市公司治理准则》《上市公司独立董事管理办法》等有关法律、法规以及《公 司章程》《独立董事工作制度》等公司制度的规定，在2024年度工作中，本人定 期了解公司经营情况，认真履行独立董事的职责，恪尽职守，勤勉尽责。积极出 席相关会议，认真审阅会议议案及相关材料，积极参与各议题的讨论，对公司重 点关注事项发表了意见，切实维护了公司和股东特别是中小股东的合法权益。根 据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 有关要求，现就本人在2024年度履行独立董事职责的情况报告如下： 一、基本情况 本人陆正华，汉族，1962年出生，中国国籍，未有任何国家和地区的永久海 外居留权，博士。曾任广东汕头超声电子股份有限公司独立董事、广东肇庆星湖 生物科技股份有限公司独立董事、华南理工大学工商管理学院副教授、硕士生导 师等。现任公司独立董事、敏捷控股有限公司独立非执行董事、广州达意隆包装 机械股份有限公司独立董事、广州白云国际机场股份有限公司独立董事。 报告期内，本人任职 ...

温氏食品集团股份有限公司 独立董事杜连柱2024年度述职报告 作为温氏食品集团股份有限公司（以下简称"公司"）的独立董事，本人根据 《上市公司治理准则》《上市公司独立董事管理办法》等有关法律、法规以及《公 司章程》《独立董事工作制度》等公司制度的规定，在2024年度工作中，本人定 期了解公司经营情况，认真履行独立董事的职责，恪尽职守，勤勉尽责。积极出 席相关会议，认真审阅会议议案及相关材料，积极参与各议题的讨论，对公司重 点关注事项发表了意见，切实维护了公司和股东特别是中小股东的合法权益。根 据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 有关要求，现就本人在2024年度履行独立董事职责的情况报告如下： 一、基本情况 本人杜连柱，汉族，1979年出生，中国国籍，未有任何国家和地区的永久海 外居留权，博士。2008年以来任职于农业农村部环境保护科研监测所，现为农业 农村部环境保护科研监测所研究员、博士生导师、养殖业污染防治团队首席科学 家，兼任中国沼气学会理事，公司独立董事。 报告期内，本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求，不存在影响独立性的情况。 二、年度 ...

董事会对独立董事独立性自查情况的专项报告 2025 年 4 月 23 日 1 根据《上市公司独立董事管理办法》、《深圳证券交易所上 市公司自律监管指引第2号——创业板上市公司规范运作》等要求， 并结合独立董事出具的《独立董事关于2024年度独立性的自查报 告》，温氏食品集团股份有限公司（以下简称"公司"）董事会， 就公司在任独立董事陆正华、欧阳兵、江强、杜连柱的独立性情 况进行评估并出具如下专项意见： 经核查公司独立董事的任职经历以及签署的相关自查文件， 上述人员均未在公司担任除独立董事以外的任何职务，也未在公 司主要股东公司担任任何职务，与公司以及主要股东之间不存在 利害关系或其他可能妨碍其进行独立客观判断的关系，不存在其 他影响独立董事独立性的情况，公司独立董事符合《上市公司独 立董事管理办法》《深圳证券交易所上市公司自律监管指引第2号 ——创业板上市公司规范运作》中对独立董事独立性的相关要求。 温氏食品集团股份有限公司董事会 温氏食品集团股份有限公司 ...

温氏食品集团股份有限公司 独立董事欧阳兵2024年度述职报告 作为温氏食品集团股份有限公司（以下简称"公司"）的独立董事，本人根据 《上市公司治理准则》《上市公司独立董事管理办法》等有关法律、法规以及《公 司章程》《独立董事工作制度》等公司制度的规定，在2024年度工作中，本人定 期了解公司经营情况，认真履行独立董事的职责，恪尽职守，勤勉尽责。积极出 席相关会议，认真审阅会议议案及相关材料，积极参与各议题的讨论，对公司重 点关注事项发表了意见，切实维护了公司和股东特别是中小股东的合法权益。根 据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 有关要求，现就本人在2024年度履行独立董事职责的情况报告如下： 一、基本情况 本人欧阳兵，汉族，1975年出生，中国国籍，未有任何国家和地区的永久海 外居留权，本科学历。2008年至今担任广东岭南律师事务所合伙人，现兼任中国 广州仲裁委员会仲裁员，广州南沙新区（自贸片区）法商研究院研究员，公司独 立董事。 报告期内，本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求，不存在影响独立性的情况。 二、年度履职概况 （一）董事会和股东大会 ...

Financial Performance - The company's operating revenue for 2024 reached ¥104.86 billion, an increase of 16.64% compared to ¥89.90 billion in 2023[23]. - The net profit attributable to shareholders was ¥9.23 billion, a significant turnaround from a loss of ¥6.39 billion in 2023, representing a 244.46% increase[23]. - The net cash flow from operating activities was ¥19.59 billion, up 157.92% from ¥7.59 billion in the previous year[23]. - The company's total revenue for the reporting period reached CNY 10,492.44 million, an increase of 16.68% compared to the previous year[115]. - The net profit attributable to shareholders was CNY 923.04 million, a significant increase of 244.46% year-on-year[115]. - The total assets at the end of 2024 were ¥93.86 billion, a slight increase of 1.04% from ¥92.90 billion in 2023[23]. - The equity attributable to shareholders increased by 23.87% to CNY 4,095.23 million[115]. - The total profit for the reporting period reached 9.572 billion yuan, a year-on-year increase of 250.26%, with net profit attributable to shareholders at 9.230 billion yuan, up 244.46%[117]. Market and Sales Performance - The company sold 1.208 billion chickens in 2024, a year-on-year increase of 2.09%, capturing 8.41% of the national market share[33]. - The company sold 30.18 million pigs, reflecting a 14.93% growth, accounting for 4.30% of the national pig market[33]. - Sales of pork products increased by 33.71% to ¥64.85 billion, representing 61.85% of total revenue, while chicken sales slightly decreased by 2.58% to ¥35.72 billion[128]. - The total sales volume of pork reached 3,018.27 million heads, reflecting a growth of 14.93% from 2,626.22 million heads in 2023[131]. - The average selling price of meat pigs rose by 12.83% to CNY 16.71 per kilogram, while the average price of meat chickens fell by 4.60% to CNY 13.06 per kilogram[116]. Production and Operations - The company has a registered capital of 1.5 billion RMB, reflecting its substantial financial foundation[19]. - The company employs a close "company + farmer" model, where it signs contracts with cooperative farmers for breeding, providing technical support and management throughout the process[79]. - The company has a total of 43,000 cooperative farmers, with regional distribution as follows: South China 40.42%, East China 21.63%, Central China 16.97%, Southwest 15.13%, North China 3.78%, Northwest 1.15%, Northeast 0.92%[84]. - The company has a dual main business model with chicken and pig farming, which helps mitigate the impact of industry cycles on operational performance[100]. - The company has developed a leading position in chicken breeding, with approximately 50 varieties of quality chicken breeds and 9 breeding systems certified by national standards[102]. Research and Development - The company invested CNY 675 million in R&D during the reporting period, resulting in 222 new research projects and 25 authorized invention patents[109]. - The company has established a robust "industry-university-research" technology R&D system, collaborating with several universities to drive continuous technological innovation and maintain industry leadership[101]. - The company has implemented a smart marketing project that successfully pushed product information to over 3,000 customers, resulting in a sales increase of 670,000 broilers[142]. - The company has established a second-generation and third-generation sequencing platform, improving the efficiency and reliability of pathogen genome sequencing[143]. Risk Management - The company emphasizes the importance of risk awareness among investors, highlighting risks such as policy, competition, price fluctuations, and disease outbreaks[5]. - The company has established strict risk control measures for commodity futures hedging, including a separation of decision-making and execution functions[166]. - The company has implemented hedging strategies using financial derivatives and commodity futures to mitigate price volatility risks associated with its production and sales operations[166]. Investment and Funding - The total amount raised for the pig farming biosecurity upgrade project is RMB 17,194.11 million, with an actual investment of RMB 7,798.99 million, achieving an investment progress of 83.22%[198]. - The company has a remaining balance of 29,550,969.85 CNY in its special account for raised funds[173]. - The company has approved the use of up to 200 million yuan of idle fundraising funds to supplement working capital, with a repayment period not exceeding 12 months[193]. - The company has raised 270.9 million for working capital, fully utilizing the funds[186]. Environmental and Social Responsibility - The company has been focusing on environmental protection since 2004, promoting sustainable development and waste resource utilization[108]. - The company has established a comprehensive disease prevention and biosecurity system to ensure stable production[106]. - The company is focused on integrating crop planting with livestock farming to improve resource utilization and reduce costs[140]. Strategic Outlook - The company's future outlook and strategic plans are subject to market conditions and investor risk awareness[5]. - The company is transitioning its operational model from "company + farmers" to "company + modern breeding areas + farmers" to leverage scale advantages[190]. - The company aims to enhance its market position through the development of new technologies and expansion of its breeding capabilities[179].

Financial Performance - The company's revenue for Q1 2025 reached ¥24.32 billion, an increase of 11.34% compared to ¥21.84 billion in the same period last year[3]. - Net profit attributable to shareholders was ¥2.00 billion, a significant increase of 261.92% from a loss of ¥1.24 billion in the previous year[3]. - Basic earnings per share rose to ¥0.3025, compared to a loss of ¥0.1868 in the same quarter last year, marking a 261.94% improvement[3]. - The total operating revenue for the current period reached ¥24,331,217,676.45, an increase of 11.4% compared to ¥21,847,552,671.51 in the previous period[25]. - The net profit for the current period was ¥2,074,230,406.61, a significant recovery from a net loss of ¥1,256,626,114.34 in the previous period[26]. - The company's operating costs decreased to ¥22,392,829,270.05 from ¥22,923,312,201.66, a reduction of about 2.3%[25]. - The company reported a total comprehensive loss of -¥251,202,032.43, compared to -¥175,463,007.11 in the previous period[39]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥3.82 billion, representing a 69.02% increase from ¥2.26 billion in Q1 2024[3]. - The net increase in cash and cash equivalents was ¥228.16 million, a decrease of 93.06% compared to ¥3.29 billion in the same quarter last year[11]. - The ending balance of cash and cash equivalents was CNY 8,014,398,770.80, down from CNY 9,413,336,939.86, reflecting a decrease of 14.8%[32]. - Total cash inflow from operating activities reached CNY 23,957,569,153.16, up from CNY 21,897,127,142.22, reflecting a growth of 9.4%[30]. - Cash outflow from operating activities was CNY 20,138,458,907.05, compared to CNY 19,637,631,986.58, indicating an increase of 2.5%[30]. - Investment activities generated a net cash outflow of CNY -2,257,980,128.34, worsening from CNY -1,548,464,049.31 in the previous period[30]. Assets and Liabilities - Total assets at the end of Q1 2025 were ¥95.02 billion, up 1.23% from ¥93.86 billion at the end of the previous year[3]. - The total liabilities decreased to ¥48,882,619,220.69 from ¥49,880,145,648.94, indicating a reduction of approximately 2%[24]. - Total assets increased to CNY 82,575,486,482.71 from CNY 81,687,402,768.24, representing a growth of 1.1%[36]. - Total liabilities rose to CNY 35,071,909,849.37, compared to CNY 34,033,570,566.62, indicating an increase of 3.1%[36]. - The company's equity attributable to shareholders increased by 5.13% to ¥43.05 billion from ¥40.95 billion at the end of the previous year[3]. Investments and Expenses - Research and development expenses increased to ¥142,343,765.15 from ¥127,250,232.56, representing a growth of 11.9%[26]. - Financial expenses decreased by 32.77% to ¥189.96 million due to reduced borrowings and interest expenses[11]. - Investment activities generated a net cash flow of ¥1,522,943,548.38, an increase from ¥1,001,744,137.56 in the previous period[40]. - Sales expenses rose to ¥26,188,033.76 from ¥18,803,186.55, suggesting increased marketing efforts[38]. Strategic Outlook - The company plans to continue expanding its market presence and investing in new technologies to enhance operational efficiency[17]. - The management indicated a positive outlook for the upcoming quarters, expecting growth in revenue driven by new product launches and market expansion strategies[17]. - The company is focusing on strategic acquisitions to bolster its market position and diversify its product offerings[17].

智通财经4月23日电，温氏股份(300498.SZ)公告称，2025年第一季度实现营业收入243.18亿元，同比增 长11.34%；归属于上市公司股东的净利润为20.01亿元。主要原因是肉猪业经营盈利。 温氏股份：第一季度净利润20.01亿元 同比扭亏为盈 ...

温氏食品集团股份有限公司（以下简称"公司"）于2024年4月 26日召开第四届董事会第二十五次会议，审议通过了《关于使用 部分闲置募集资金暂时补充流动资金的议案》，同意公司在保证 募集资金投资项目的资金需求的前提下，使用部分闲置募集资金 总额不超过350,000万元用于暂时补充流动资金，使用期限自公司 董事会审议通过之日起不超过12个月，到期前将及时、足额归还 到募集资金专用账户。具体详情请见公司于2024年4月29日在中国 证监会指定创业板信息披露网站巨潮资讯网发布的《关于使用部 分闲置募集资金暂时补充流动资金的公告》（公告编号：2024-49）。 根据上述决议，公司在规定期限内实际使用了人民币300,000 万元闲置募集资金暂时补充流动资金，并对资金进行了合理的安 排与使用，没有影响募集资金投资项目的正常进行，资金运用情 况良好。 2025年4月18日，公司已将上述暂时补充流动资金的闲置募集 1 温氏食品集团股份有限公司 资金300,000万元归还至公司募集资金专用账户，使用期限未超过 12个月。截至本公告披露日，公司用于暂时补充流动资金的闲置 募集资金已全部归还，并将上述募集资金的归还情况通知了公司 的 ...

本周猪价上涨 根据博亚和讯，4月11日全国外三元生猪均价为14.66元/kg，周环比+0.41%，15公斤仔猪均价37.2元/公 斤，周环比上涨0.32%。根据涌益咨询数据，本周商品猪出栏均重为128.81kg，周环比下降0.08kg，全国冻 品库容率为14.94%，环比上升0.11pct。本周涌益出栏均重结束了2月初以来的持续上行，对应行业库存拐 点初步显现。考虑到当前二育增重利润已大幅降低，4月有望正式进入去库周期，建议持续关注均重水 平。 3月猪企销售月报解读 （1）出栏量：经历了2月的季节性缩量后，3月出栏量明显回升。13家上市猪企合计出栏生猪1718.98万 头，环比+26.67%，同比+44.43%。头部集团中，牧原股份/温氏股份/新希望的生猪出栏总量环比分别 +30.24%/+19.14%/+36.01%。在中游企业中，除天康生物出栏环比下降，以及ST天邦、唐人神增幅较小之 外，其余企业总出栏量环比增长均较为显著，大部分增幅在20%-40%之间。具体来看，1）商品猪方面：3 月13家上市猪企出栏商品猪总量约为1371.31万头，环比+20.65%，同比+28.54%。根据前期新生仔猪来 看，3月 ...